Concepedia

Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration

Julia Hoellenriegel, Greg Coffey, Uma Sinha, Anju Pandey, Mariela Sivina, Alessandra Ferrajoli, Farhad Ravandi, William G. Wierda, Susan O’Brien, Michael J. Keating,

Leukemia · 2012 · 141 citations · 39 references

DOI

Concepts

References

39

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

Michael Hallek, Kirsten Fischer, Guenter Fingerle-Rowson et al. · The Lancet · 2010 · 1.9K citations

, , +10

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

R. Eric Davis, Vu N. Ngo, Georg Lenz et al. · Nature · 2010 · 1.6K citations · Full text

, , +14

Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia

Andreas Rosenwald, Ash A. Alizadeh, George F. Widhopf et al. · The Journal of Experimental Medicine · 2001 · 1.1K citations · Full text

, , +17

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

Michael J. Keating, Susan O’Brien, Maher Albitar et al. · Journal of Clinical Oncology · 2005 · 951 citations · Full text

, , +14

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

Yair Herishanu, Patricia Pérez‐Galán, Delong Liu et al. · Blood · 2010 · 815 citations

, , +16